AstraZeneca completes sale of Zeneca specialities

ASTRAZENECA COMPLETES SALE OF ZENECA SPECIALITIES AstraZeneca today completed the previously announced sale of its Zeneca Specialities business for a cash amount of $2.1 billion (£1.3) in a buyout jointly financed by Cinven and Investcorp. Further enquiries: Media: Steve Brown, Media Relations Manager, tel +44 171 304 5033 ------------------------------------------------------------ Please visit for further information The following files are available for download: